Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_assertion type Assertion NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_head.
- NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_provenance.
- NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_assertion evidence source_evidence_literature NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_provenance.
- NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_assertion SIO_000772 18473355 NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_provenance.
- NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_assertion wasDerivedFrom befree-2016 NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_provenance.
- NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_assertion wasGeneratedBy ECO_0000203 NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_provenance.